Among patients with MMD, the homozygous variant of RNF213 4810G > A was associated with an increased likelihood of onset at a younger age, cerebral infarction at diagnosis, and cognitive impairment during long-term follow-up [34]. This evidence concerns the gene RNF213 and Cognitive impairment.